These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 6391928)

  • 1. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis.
    Katona G; Vargas RB
    Eur J Rheumatol Inflamm; 1983; 6(3):233-41. PubMed ID: 6391928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of naproxen and indomethacin in rheumatoid arthritis.
    Castles JJ; Moore TL; Vaughan JH; Bolzan JA; Lee M; Lidsky MD; Caldwell JR; Ehrlich GE; Sharp JT; Kaye R
    Arch Intern Med; 1978 Mar; 138(3):362-6. PubMed ID: 343743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
    Devereaux MD; Douglas WA
    Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.
    Chlud K; Pangerl S
    Pharmatherapeutica; 1985; 4(2):113-21. PubMed ID: 3903778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
    de Queiros MF
    Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW; Kivitz AJ; Brown MT; Verburg KM
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis.
    Khan FM
    Clin Ther; 1983; 5(5):483-7. PubMed ID: 6352034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with naproxen in rheumatoid arthritis.
    Alexander SJ
    Arch Intern Med; 1975 Nov; 135(11):1429-35. PubMed ID: 1103765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing dose of naproxen in rheumatoid arthritis: use with and without corticosteroids.
    Luftschein S; Bienenstock H; Varady JC; Stitt FW
    J Rheumatol; 1979; 6(4):397-404. PubMed ID: 392094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two double blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritis.
    Kolodny AL
    J Rheumatol; 1988 Aug; 15(8):1205-11. PubMed ID: 3054094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diflunisal compared with naproxen in chronic polyarthritis. Double-blind study].
    Baumgartner H; Boyle CM
    Schweiz Med Wochenschr; 1982 Feb; 112(8):281-5. PubMed ID: 7043728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossover comparison of benoxaprofen and naproxen in rheumatoid arthritis.
    Atkinson MH; Brown TA; Robinson HS; Willkens RF
    J Rheumatol Suppl; 1980; 6():109-15. PubMed ID: 6993666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diflunisal versus naproxen in the management of rheumatoid arthritis.
    Osborn TG; Parks RL; Moore TL; Grisanti MW; Nesher G; Caciolo BA
    Clin Ther; 1989; 11(6):736-43. PubMed ID: 2692819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
    Schnitzer TJ; Kamin M; Olson WH
    Arthritis Rheum; 1999 Jul; 42(7):1370-7. PubMed ID: 10403264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoprofen compared with naproxen and placebo in rheumatoid arthritis.
    Berry H; Fernandes L; Clarke AK; Hamilton EB; Davies J; Dixon AS
    Eur J Rheumatol Inflamm; 1981; 4(1):87-92. PubMed ID: 7042367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study.
    Larsen A
    Int J Clin Pharmacol Res; 1985; 5(1):17-23. PubMed ID: 3888863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis.
    Kjeldsen-Kragh J; Lund JA; Riise T; Finnanger B; Haaland K; Finstad R; Mikkelsen K; Førre O
    J Rheumatol; 1992 Oct; 19(10):1531-6. PubMed ID: 1464864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
    Edwards W
    Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.